The market is experiencing growth due to the increasing prevalence of cancer and cardiovascular diseases. This trend is coupled with a growing adoption of digital imaging technology, which offers more comprehensive diagnostic capabilities.
Advancements in PET-CT scanner technology have led to improved image quality and reduced scan times, enhancing patient comfort and diagnostic accuracy. These improvements are driving the rising demand for early and accurate disease diagnosis, particularly in oncology and neurology.
The integration of artificial intelligence and machine learning in image analysis is revolutionizing the interpretation of PET-CT scans, leading to more precise diagnoses. This technological progress aligns with the broader shift towards personalized medicine and targeted therapies.
Increasing investments in healthcare infrastructure and the modernization of imaging facilities are contributing to the expansion of the PET-CT scanner market in the United States. These investments enable healthcare providers to offer advanced diagnostic services to their patients.
The growing emphasis on preventive healthcare and regular health screenings is boosting the demand for PET-CT scans as a proactive diagnostic tool. This trend is particularly evident in oncology, where early detection can significantly improve treatment outcomes.
Advancements in radiopharmaceuticals are expanding the applications of PET-CT imaging. New tracers are being developed to target specific diseases or cellular processes, enhancing the diagnostic capabilities of PET-CT scanners across various medical specialties.
The increasing adoption of value-based healthcare models is driving the demand for cost-effective diagnostic solutions. PET-CT scanners, with their ability to provide comprehensive diagnostic information in a single examination, are well-positioned to meet this demand.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The U.S. PET-CT scanner industry was valued at approximately USD 864 million in 2023 and is estimated to grow at a 5.9% CAGR from 2024 to 2032, driven by advancements in medical imaging technology.
The digital PET-CT scanner segment recorded USD 511.8 million in 2023 and is expected to grow significantly due to superior resolution, increased sensitivity, and long-term stability offered by advanced digital photon-counting technology.
Northeast U.S. PET-CT scanner industry generated USD 177.1 million in 2023 and is projected to witness substantial growth, supported by a robust healthcare infrastructure with numerous academic medical centers and hospitals.
Key players in the market include Bruker Corporation, Canon, GE HealthCare, Koninklijke Philips, Mediso, MinFound Medical Systems, MR Solutions, and Neusoft Medical Systems.